XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 20,510 $ 13,338 $ 56,945 $ 30,460
General and administrative 8,504 6,898 25,022 18,371
Total operating expenses 29,014 20,236 81,967 48,831
Loss from operations (29,014) (20,236) (81,967) (48,831)
Other income (expense):        
Interest and investment income 4,517 2,527 13,405 7,404
Other expense, net (37) (18) (72) (54)
Total other income, net 4,480 2,509 13,333 7,350
Net loss $ (24,534) $ (17,727) $ (68,634) $ (41,481)
Net loss per share attributable to common shareholders - basic $ (0.42) $ (0.63) $ (1.24) $ (1.48)
Net loss per share attributable to common shareholders - diluted $ (0.42) $ (0.63) $ (1.24) $ (1.48)
Weighted-average common shares outstanding used in net loss per share - basic 57,820,458 28,040,173 55,542,074 28,002,663
Weighted-average common shares outstanding used in net loss per share - diluted 57,820,458 28,040,173 55,542,074 28,002,663